ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in January 2024. Updated January 31, 2024.
A roundup of FDA’s actions in January 2024.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in January 2024. Updated January 31, 2024.
A roundup of FDA’s actions in January 2024.